In opening statements in its lawsuit against Johnson & Johnson for lying about Risperdal’s risks and promoting its use for unapproved treatments, Arkansas’ lawyer Fletch Trammell said that the drug had caused deaths among elderly users and breast growth and lactation in young boys. If found guilty, Arkansas’ Medicaid fund could receive from $1.25 to $2.5 billion.
Article →
Related article:
Boston.com
***
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
***
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.
As we all know, the drug company is lying through its teeth. Among nurses and doctors this particular medicine is known to be bad and nothing but rubbish. The spokesperson for the drug company is nothing but a parrot and a shill and isn’t very convincing. I hope that Arkansas wins this case hands down, just like Texas won their case in January, to the tune of $158 million. What a bunch of slimy snakes these drug companies are. I wonder if they would allow any of their own family members to be put on their drug, or themselves? I live in Little Rock and have not heard any publicity about this case, which started this past Monday.
Report comment
Risperal reproached.
Same saga here as Eli Lilly Zyprexa.
Johnson and Johnson is a trusted brand we associate with babies.
Risperdal,Zyprexa,as well as the other atypical antipsychotics, are being prescribed for children, even though this is an unapproved, off-label use. An estimated 2.5 million children are now taking atypical antipsychotics. Over half are being given them for Attention Deficit Hyperactivity Disorder,many of these foster children.
Weight gain, increases in triglyceride levels and associated risks for (life-long) diabetes and cardiovascular disease.
Lilly made $65 billion on Zyprexa!
–Daniel Haszard
*Tell the truth don’t be afraid*
Report comment
I am on my eleventh year being chronically ill on risperdal that was prescribed to me in June 2001. THe doctor tried to take precautions but it was not good enough. 1/2 to 1 milligram of risperdal was all it took to develop the hyperglycemia condition. The diabetes developed from that little amount. Drug dealing tsunamis in America involving everything from crack, marajuana, meth—- now can count the AMerican Psychiattic Association in in the same field of deleterious activity I suppose. Since a lot of people that have the drug dealing metnality are present in the APA in my belief.
Report comment